๐Ÿฅ VAERS Vaccine Data Browser

๐Ÿ”’ Privacy & Data Disclaimer

About This Site

This is a public data browser for the Vaccine Adverse Event Reporting System (VAERS). By using this site, you acknowledge and agree to the following:

Data Source & Accuracy

  • Public Data: All data displayed comes from the publicly available VAERS database maintained by the CDC and FDA.
  • No Verification: VAERS accepts all reports without verifying medical accuracy. Reports do not prove causation between vaccines and adverse events.
  • Anyone Can Report: Healthcare providers, patients, family members, and anyone else can submit reports to VAERS.
  • Research Purpose: This data is for transparency, research, and monitoring vaccine safety signals only.

Your Privacy

  • No Personal Data Collection: This site does not collect, store, or track any personal information about visitors.
  • No Cookies: We do not use cookies except for remembering that you've seen this disclaimer (stored locally in your browser).
  • No Analytics: We do not use Google Analytics or any other tracking services.
  • Search Privacy: Your searches and filters are not logged or stored on our servers.
  • Public Data Only: The VAERS data shown here is already public and contains no personally identifiable information.

Medical Disclaimer

  • Not Medical Advice: This tool is for informational purposes only and does not provide medical advice.
  • Consult Healthcare Providers: Always consult qualified healthcare professionals for medical decisions.
  • No Liability: We are not responsible for decisions made based on this data.

Data Interpretation

  • The presence of a report does not mean the vaccine caused the adverse event.
  • Coincidental events are often reported (e.g., a heart attack that happened to occur after vaccination).
  • Serious adverse events must be reported by law, even if unrelated to the vaccine.
  • The database is useful for detecting safety signals that require further investigation.

๐Ÿ“– Help & Search Guide

Column Icons Legend

๐Ÿ’€ Death
๐Ÿฅ Hospitalized
๐Ÿš‘ Emergency Room
โ™ฟ Disability
โš ๏ธ Life Threatening

How to Search

๐Ÿ’ก Search Tips:
  • Select Year: Choose a specific year OR "All Years" to search across all data
  • All Years requires filters: When searching all years, you must select at least one filter (lot number, vaccine type, outcome, etc.) for performance
  • Lot number tracking: Use "All Years" + Lot Number to track lots across multiple years
  • Combine filters: Use multiple filters together to narrow results (e.g., Age + Vaccine Type + Death)
  • VAERS ID: Search for specific report by ID number
  • Age: Enter exact age (e.g., 25) or decimal (e.g., 0.5 for 6 months)
  • State: Enter 2-letter state code (e.g., CA, NY, TX)
  • Vaccine Type: Search partial names (e.g., "COVID19", "FLU", "HPV")
  • Manufacturer: Search by company (e.g., "PFIZER", "MODERNA")
  • Lot Number: Search specific vaccine lot (works great with "All Years")
  • Symptoms: Search for any symptom keyword (e.g., "fever", "rash")
  • Death/Hospitalized: Filter to only show cases with these outcomes

Understanding the Data

  • Reports are unverified: VAERS accepts all reports without medical verification
  • Not proof of causation: A report does not mean the vaccine caused the event
  • Anyone can report: Healthcare providers, patients, and family members can submit reports
  • Multiple vaccines: One report may list multiple vaccines given at the same time
  • Blank fields: Not all fields are required, so some data may be missing

Using the Table

  • Sort columns: Click column headers (ID, Age, Sex, Date, Died) to sort
  • Expand text: Click "More" to see full narrative or symptom text
  • Navigate pages: Use pagination controls at top and bottom of table
  • Export results: Click "๐Ÿ“ฅ Export CSV" to download filtered data (max 10,000 records)

๐Ÿ’ก Frequently Asked Questions (FAQ)

What is this site?

๐Ÿฅ VAERS Vaccine Data Browser is an independent, third-party data browser for publicly available VAERS (Vaccine Adverse Event Reporting System) data.

Important: This site is NOT affiliated with, endorsed by, or operated by the CDC, FDA, or any government agency. We are an independent service that makes public VAERS data easier to search and analyze.

What is VAERS?

VAERS (Vaccine Adverse Event Reporting System) is a national early warning system established in 1990 to detect possible safety problems with vaccines. It's co-managed by the CDC (Centers for Disease Control and Prevention) and FDA (Food and Drug Administration).

VAERS accepts and analyzes reports of adverse events (possible side effects) after a person has received a vaccination.

Official VAERS website: vaers.hhs.gov

Is this data HIPAA compliant?

Yes, absolutely. All VAERS data displayed here is:

  • Publicly available - Published by the CDC/FDA on their official website
  • De-identified - Contains no personally identifiable information (names, addresses, contact info removed)
  • Legally accessible - Available to researchers, media, and the general public under FOIA (Freedom of Information Act)
  • Not protected health information - Once de-identified and published by the government, it's no longer covered by HIPAA restrictions

This site displays the same public data available at vaers.hhs.gov/data.

Why does this site exist?

We believe in transparency and public access to health data. While the CDC/FDA provide VAERS data, their official site:

  • Is difficult to search and filter
  • Requires downloading large CSV files and technical knowledge
  • Is not user-friendly for the average person

This independent site makes the same publicly available data easier to search, filter, and understand for researchers, journalists, healthcare workers, and concerned citizens.

Where does the data come from?

All data is downloaded directly from the official CDC/FDA VAERS website at vaers.hhs.gov/data.

The data is:

  • Publicly released by the CDC/FDA every week
  • Available as downloadable CSV files
  • Imported into this site's database for easier searching
  • Displayed exactly as provided (no modifications or filtering)

This site does not collect, modify, or add to the official VAERS data.

My vaccine lot number matches one with deaths/serious events - should I be worried?

Important context:

  • VAERS reports do NOT prove causation - A report means an event occurred after vaccination, but doesn't mean the vaccine caused it
  • Anyone can report - Reports are not verified for medical accuracy before being published
  • Coincidences happen - When millions of people get vaccinated, some will experience unrelated medical events afterward
  • Large lot numbers - Popular vaccines may have hundreds of thousands of doses from one lot number
  • More vaccinations = more reports - Lots used widely will naturally have more reports

What to do:

  • Don't panic - VAERS data requires expert analysis to interpret
  • Talk to your doctor if you have concerns
  • Check official CDC/FDA safety communications for genuine safety signals
  • Remember: billions of vaccine doses have been safely administered

Can I trust VAERS data?

VAERS is valuable but has limitations:

Strengths:

  • โœ… Early warning system for potential safety signals
  • โœ… Open and transparent - publicly accessible
  • โœ… Accepts all reports regardless of likelihood of causation
  • โœ… Monitored by CDC/FDA experts who investigate concerning patterns

Limitations:

  • โš ๏ธ Reports are unverified - not investigated before publication
  • โš ๏ธ Cannot determine if vaccine caused the event
  • โš ๏ธ Underreporting - not all adverse events are reported
  • โš ๏ธ Overreporting - coincidental events may be reported
  • โš ๏ธ Incomplete data - not all fields are required

Bottom line: VAERS is an important tool for safety monitoring, but individual reports should not be used as proof that a vaccine caused harm.

What are "adverse events"?

An adverse event is any undesirable health occurrence that happens after vaccination, including:

  • Common reactions: Sore arm, mild fever, fatigue (usually expected)
  • Serious events: Hospitalization, disability, life-threatening illness, death
  • Coincidental events: Medical conditions that would have occurred anyway

Important: An adverse event doesn't mean the vaccine caused it - only that it occurred after vaccination. Many reported events are coincidental or unrelated.

Why are some lot numbers listed multiple times?

This is normal and expected! A person may receive multiple doses of the same vaccine from the same lot number:

  • COVID vaccines require 2-3 doses
  • HPV, Hepatitis B, and other vaccines have multi-dose schedules
  • Each dose is recorded as a separate entry

Example: Person receives Pfizer COVID dose 1 (lot ABC123) and dose 2 (lot ABC123) - lot ABC123 appears twice in their report.

How often is this data updated?

The CDC/FDA releases new VAERS data every Friday. This site is typically updated:

  • Weekly or bi-weekly for recent data
  • Check the available years to see what data is currently loaded
  • During updates, the site may be in maintenance mode temporarily

Where can I learn more?

โš ๏ธ DISCLAIMER: This data is from the Vaccine Adverse Event Reporting System (VAERS). Reports do not establish causation between vaccines and adverse events. Anyone can submit a report, and reports are not verified. This is raw data for transparency and research purposes only.
34,052
Total Reports (2025)
500
Deaths Reported
1,634
Hospitalizations
30
ER Visits
1,191
Disabilities
570
Life Threatening
๐Ÿ”„ Reset ๐Ÿ“ฅ Export CSV
ID Age Sex State Date โ–ผ Onset Days Vaccine Manufacturer Lot # Symptoms Narrative ๐Ÿ’€ ๐Ÿฅ ๐Ÿš‘ โ™ฟ โš ๏ธ
2842384 79 M FL 05/22/2025 TDAP
GLAXOSMITHKLINE BIOLOGICALS
L5229
Unevaluable event Unevaluable event
NONE NONE
2842385 22 M OH 05/22/2025 COVID19
COVID19
COVID19
COVID19
COVID19
COVID19
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
PFIZER\BIONTECH
FC3181
FC3181
FC3181
FF2587
FF2587
FF2587
Arrhythmia, Asthenia, Blood thyroid stimulating hormone increased, Chest pain, E... Arrhythmia, Asthenia, Blood thyroid stimulating hormone increased, Chest pain, Electrocardiogram abnormal; Fatigue, Fibrin D dimer normal, Full blood count normal, Hypertension, Immune system disorder; Myalgia, Pain, Pain in extremity, Ultrasound scan normal; Arrhythmia, Asthenia, Blood thyroid stimulating hormone increased, Chest pain, Electrocardiogram abnormal; Fatigue, Fibrin D dimer normal, Full blood count normal, Hypertension, Immune system disorder; Myalgia, Pain, Pain in extremity, Ultrasound scan normal More
Have gone to ER for shooting muscle pains. Feel like I've aged 10 years in 4 since the vax. Fat... Have gone to ER for shooting muscle pains. Feel like I've aged 10 years in 4 since the vax. Fatigue and lack of energy namely. Stamina loss and Heart arrythmia. Immune system has severely decreased. I had a persistent chest pain for 3 months that would flare up at different times that only subsided after months of max supplementing potassium in my diet. I have changed all the variables of my lifestyle in favor of my health and yet my immune system is worse than it was when I was treating it like crap pre-vaccine. Pain continues at random points in legs, exact location varies as well. Ultrasound on right leg was negative. More
2842386 34 F WA 05/22/2025 MMR
TDAP
MERCK & CO. INC.
GLAXOSMITHKLINE BIOLOGICALS
Y011709
M2G3Z
Extra dose administered, No adverse event; Extra dose administered, No adverse e... Extra dose administered, No adverse event; Extra dose administered, No adverse event More
No adverse event. Just reporting it as it is an extra dose. No adverse event. Just reporting it as it is an extra dose.
2842388 10 F CA 05/22/2025 HPV9
MERCK & CO. INC.
Y012864
Flushing, Urticaria Flushing, Urticaria
After receiving HPV 9 vaccine at 4:54 PM, approximately 5-10min later patient reported having hives ... After receiving HPV 9 vaccine at 4:54 PM, approximately 5-10min later patient reported having hives and was flush in the face. Charge Nurse checked on patient and informed Provider of symptoms and then she evaluated patient. Provider then ordered Benadryl 12.5 mg/5ml oral elixir 25mg and it was given at 5:19 PM. Patient was better and denied any other symptoms by 5:30 PM. Patient discharged by 5:40 PM with caregiver. More
2842389 15 F WA 05/22/2025 VARCEL
MERCK & CO. INC.

Fatigue, Oropharyngeal pain, Vasodilatation Fatigue, Oropharyngeal pain, Vasodilatation
Swollen neck veins, exhaustion, and sore throat. Swollen neck veins, exhaustion, and sore throat.
2842404 11 F HI 05/22/2025 HPV9
MNQ
TDAP
MERCK & CO. INC.
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
Z005055
U8493AA
KR75K
Hypoaesthesia; Hypoaesthesia; Hypoaesthesia Hypoaesthesia; Hypoaesthesia; Hypoaesthesia
See printed 05/08/2025 and 05/09/2025 medical / clinical notes / documentation. Phone call w/fathe... See printed 05/08/2025 and 05/09/2025 medical / clinical notes / documentation. Phone call w/father. Last night, applied hot & cold compress to child's left forearm. At 7pm last night, father said child was able to feel a little below her left elbow. Father said while he was working today at 6:30am, child's mother called him & told him child's left forearm is able to feel again. Father also said he and child's mother does not want child to receive the 2nd HPV vaccination. After leaving our office after examination & vaccination, child opened the car door and was unable to feel w/her left forearm, from her left elbow to her fingers (HPV vaccination was admin in her left deltoid). Child returned to Dr's office. Dr. examined child. Child was able to move her upper left extremity but was unable to feel below her left elbow to her fingers. 4:23PM, 2 ibuprofen 200mg tablets given PO, 4:40PM, there was no change to child's left forearm. Dr recommended hot & cold compress during the night and to call her PRN. More
2842405 4 F NY 05/22/2025 DTAP
IPV
MMR
VARCEL
SANOFI PASTEUR
SANOFI PASTEUR
MERCK & CO. INC.
MERCK & CO. INC.
3CA20C1
Y1A212M
Y019108
Y019318
Injection site reaction; Injection site reaction; Injection site reaction; Injec... Injection site reaction; Injection site reaction; Injection site reaction; Injection site reaction More
Large local reaction (R) upper arm Large local reaction (R) upper arm
2842406 12 M MT 05/22/2025 HPV9
MNQ
TDAP
MERCK & CO. INC.
NOVARTIS VACCINES AND DIAGNOSTICS
GLAXOSMITHKLINE BIOLOGICALS
Y015179
57H54
EB499
Injection site bruising; Injection site bruising; Injection site bruising Injection site bruising; Injection site bruising; Injection site bruising
Bruising at injection site. Noticed after shower 2 days after injection. Not painful or bothersome t... Bruising at injection site. Noticed after shower 2 days after injection. Not painful or bothersome to patient. More
2841927 1 HI 05/21/2025 MMRV
MERCK & CO. INC.
Y017511
No adverse event, Product storage error No adverse event, Product storage error
No other information provided. No additional AEs/PQC reported.; vaccines administered after temperat... No other information provided. No additional AEs/PQC reported.; vaccines administered after temperature excursions; This spontaneous report was received from an Other health professional and refers to a(n) 1-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant medications included Hepatitis A Vaccine, Inactivated (VAQTA) (manufacturer unknown) Prevenar 20 (Pneumococcal vaccine conj 20v (CRM197)) . On 15-Apr-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), lot #Y017511, expiration date: 15-Apr-2026, dose number 1, (strength, dose, and vaccination scheme were not reported), administered by Subcutaneous route in Left Thigh, as Prophylaxis. On an unknown date, the vaccine underwent a temperature excursion of -9.8 Celsius Degrees during a timeframe of 2 h 3 m, with no previous temperature excursions. No adverse event was reported.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : , Index date : 2025-04-28 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : , Central date : 2025-04-28 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number : More
2841928 4 M IL 05/21/2025 MMRV
MMRV
MERCK & CO. INC.
MERCK & CO. INC.
X026409

Expired product administered, No adverse event; Expired product administered, No... Expired product administered, No adverse event; Expired product administered, No adverse event More
No symptoms reported; an expired dose of PROQUAD was administered to a 4-year-old male patient on 5/... No symptoms reported; an expired dose of PROQUAD was administered to a 4-year-old male patient on 5/8/2025; This spontaneous report has been received from a Nurse referring to a 4-year-old male patient. The patient's concurrent conditions, pertinent medical history, previous drug reactions/allergies, and concomitant therapies were not provided. On 08-MAY-2025, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (+) diluent, with valid lot # X026409 and expiration date: 07-May-2025 (strength, dose, frequency, route of administration, lot #, and expiration date were not provided) as prophylaxis (Expired product administered). No symptoms reported (No adverse event). More
2841929 PA 05/21/2025 MNQ
NOVARTIS VACCINES AND DIAGNOSTICS
UNK
Product preparation issue Product preparation issue
inappropriate preparation of medication; inappropriate dose of vaccine administered.; This non-serio... inappropriate preparation of medication; inappropriate dose of vaccine administered.; This non-serious case was reported by a consumer and described the occurrence of inappropriate preparation of medication in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: inappropriate preparation of medication) and inappropriate dose of vaccine administered (Verbatim: inappropriate dose of vaccine administered.). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 30-APR-2025 The reporter was the Clinic Administrator and needing some guidance on a situation that they had encountered here. The situation was that a CMA was getting a Menveo vaccine ready to administer and noticed that it was the last vial of the gray cap but that there were 2 vials of the orange caps left, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. She administered the correct dose with the two correct vials, but he/she was needing to see if there was a recommendation since we are not able to identify the patient that received only the gray top vial of the 4 other doses. The reporter had a report that identified the 4 patients. More
2841930 M NE 05/21/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
UNK
Incomplete course of vaccination Incomplete course of vaccination
He states he forgot to get dose 2 within the 2-6 month window; This non-serious case was reported by... He states he forgot to get dose 2 within the 2-6 month window; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose of vaccine in May 2024). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: He states he forgot to get dose 2 within the 2-6 month window). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date : 14-MAY-2025 The reporter stated that he received Shingrix dose 1 in May 2024. He was scheduled to get dose 2 May 20, 2025. He stated that he forgot to get dose 2 within the 2-6 month window. Till the time of reporting the patients did not receive the second dose of Shingrix, which led to incomplete course of vaccination. More
2841931 05/21/2025 VARZOS
VARZOS
UNKNOWN MANUFACTURER
UNKNOWN MANUFACTURER
UNK
UNK
Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure Herpes zoster, Vaccination failure; Herpes zoster, Vaccination failure
Suspected vaccination failure; two vaccine and still get an out break, just not as bad; This serious... Suspected vaccination failure; two vaccine and still get an out break, just not as bad; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: two vaccine and still get an out break, just not as bad). The outcome of the vaccination failure and shingles were not reported. It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine. The company considered the vaccination failure to be unrelated to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine and Shingles vaccine. Additional Information: GSK receipt date: 14-MAY-2025 This case was reported by a patient via interactive digital media. The patient had two vaccine and still get an out break, just not as bad. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting.; Sender's Comments: Vaccination failure is a listed event which, due to the following criteria ((insufficient information provided about primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles) is considered unrelated to GSK vaccine Shingles vaccine (Dose 1 & 2). More
2841932 F MO 05/21/2025 TDAP
GLAXOSMITHKLINE BIOLOGICALS
39LB7
Product storage error Product storage error
Administration after a below temperature excursion of 29.9 degree F as the minimum reached.; This no... Administration after a below temperature excursion of 29.9 degree F as the minimum reached.; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a female patient who received DTPa (Reduced antigen) (Boostrix) (batch number 39LB7) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: Administration after a below temperature excursion of 29.9 degree F as the minimum reached.). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-MAY-2025 A registered nurse asked the recommendations after giving several vaccines that were exposed to a below temperature excursion reported in case of 29.9 degree F as the lowest reached for following product Boostrix, which led to incorrect storage of vaccine. The Vaccine Administration Facility was the same as Primary Reporter. No expiration date given for the vaccines nor date of administration. The reporter consented to follow up.; Sender's Comments: US-GSK-US2025061548:Same reporter,Different patient US-GSK-US2025061574:Same reporter,Different patient US-GSK-US2025061573:Same reporter,Different patient US-GSK-US2025061572:Same reporter,Different patient US-GSK-US2025061571:Same reporter,Different patient US-GSK-US2025061570:Same reporter,Different patient US-GSK-US2025061569:Same reporter,Different patient US-GSK-US2025061568:Same reporter,Different patient US-GSK-US2025061567:Same reporter,Different patient US-GSK-US2025061565:Same reporter,Different patient US-GSK-US2025061564:Same reporter,Different patient US-GSK-US2025061563:Same reporter,Different patient US-GSK-US2025061562:Same reporter,Different patient US-GSK-US2025061561:Same reporter,Different patient US-GSK-US2025061560:Same reporter,Different patient US-GSK-US2025061559:Same reporter,Different patient US-GSK-US2025061558:Same reporter,Different patient US-GSK-US2025061557:Same reporter,Different patient US-GSK-US2025061556:Same reporter,Different patient US-GSK-US2025061555:Same reporter,Different patient US-GSK-US2025061554:Same reporter,Different patient US-GSK-US2025061553:Same reporter,Different patient US-GSK-US2025061552:Same reporter,Different patient US-GSK-US2025061551:Same reporter,Different patient US-GSK-US2025061550:Same reporter,Different patient US-GSK-US2025061549:Same reporter,Different patient US-GSK-US2025061548:Same reporter,Different patient US-GSK-US2025061547:Same reporter,Different patient US-GSK-US2025061545:Same reporter,Different patient US-GSK-US2025061538:Same reporter,Different patient US-GSK-US2025061537:Same reporter,Different patient US-GSK-US2025061536:Same reporter,Different patient US-GSK-US2025061534:Same reporter,Different patient More
2841933 NJ 05/21/2025 DTAPIPVHIB
SANOFI PASTEUR

Expired product administered, No adverse event Expired product administered, No adverse event
PENTACEL was given to patient 14 days after expiration with no reported adverse event; Initial infor... PENTACEL was given to patient 14 days after expiration with no reported adverse event; Initial information received on 14-May-2025 regarding an unsolicited valid non-serious case received from a physician. This case involves an unknown age and unknown gender patient who received diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine [Pentacel (VERO)] 14 days after expiration with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received 0.5 ml dose of suspect diphtheria/tetanus/5 hybrid ac pertussis/ipv(vero)/hib(prp/t) vaccine, Powder and suspension for suspension for injection,(lot number, expiry date and strength not reported) via unknown route in unknown administrative site for immunization, after 14 days of expiration with no reported adverse event (expired product administered) (latency: same day). Information on the batch number was requested corresponding to the one at time of event occurrence. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2841934 6 M TX 05/21/2025 TD
SANOFI PASTEUR
U7920AA
Off label use Off label use
off-label use as per local labelling due to administration of tenivac to a 6 year old patient with n... off-label use as per local labelling due to administration of tenivac to a 6 year old patient with no reported ae; Initial information received on 15-May-2025 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 6 year old male patient who received diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult [Teniva] with no reported AE (adverse event). The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-May-2025, the 6 years old male patient received an unknown dose (dose 1) of suspect diphtheria-2/tetanus-5 adsorbed toxoids no preservative adult Suspension for injection standard strength (lot U7920AA) (expiry date-unknown) via unknown route in unknown administration site for Immunization with no reported AE (off label use) (latency-same day). Reportedly-Nurse reported that the patient was 6 years old when they got their first dose of TENIVAC in the hospital and it was approved by their physician because the patient cannot get a pertussis shot. Action taken was not applicable. More
2841935 VA 05/21/2025 DTAPIPVHIB
SANOFI PASTEUR
UK168AB
No adverse event, Occupational exposure to product No adverse event, Occupational exposure to product
the liquid dripped all over her hands with no reported adverse event; the liquid dripped all over he... the liquid dripped all over her hands with no reported adverse event; the liquid dripped all over her hands with no reported adverse event; Initial information received on 15-May-2025 regarding an unsolicited valid non-serious case received from a physician. This case involves an unknown age and unknown gender physician and the diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [pentacel (vero)] dripped all over her hands with no reported adverse event. On an unknown date, the suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(vero)/HIB(PRP/T) vaccine Suspension for injection (Unknown strength) with lot UK168AB and expiry date 31-Oct-2025 for Immunization dripped all over physician hands with no reported adverse event (accidental exposure to product) (exposure via skin contact). Reportedly, Bottle leaked. Replacement requested. HCP (Healthcare professional) stated she had pentacel and that when she went to pull up the liquid to use with a patient, the bottle leaked everywhere. HCP stated that it wasn't from the needle, that it was from the bottle itself and that she was unable to use it. HCP stated she did not notice a crack in the bottle, that the leak was not coming from the needle. HCP stated that, initially, she was unable to determine where the leak was coming from, that she has seen leaks before if a needle wasn't on tight enough. HCP stated she took the needle out and put it back in, but the leaking continued. HCP stated it was then that she noticed the leak was coming from "the soft portion in the center" of the bottle. HCP stated the liquid dripped all over her hands. HCP stated she pulled a second bottle from the same box and it worked fine Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error More
2841936 0.5 AR 05/21/2025 HIBV
SANOFI PASTEUR
UK148AA
No adverse event, Product preparation issue No adverse event, Product preparation issue
reconstituted ACT-HIB with sterile water with no reported adverse event; reconstituted ACT-HIB with ... reconstituted ACT-HIB with sterile water with no reported adverse event; reconstituted ACT-HIB with sterile water and administered it to a patient; Initial information received on 19-May-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 months old with unknown gender patient who was administered with reconstituted HIB (PRP/T) Vaccine [ACT-HIB] with sterile water with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Pediarix, Rotavirus vaccine and Prevnar 20 for Immunisation. On 14-May-2025, the patient received 0.5mL (dose 3) (frequency once) of suspect HIB (PRP/T) Vaccine, Powder and solvent for solution for injection (lot UK148AA, expiry date 30-Sep-2025, strength standard) via intramuscular route in the right thigh for TB skin test (Immunisation) and reconstituted act-hib with sterile water and administered it to a patient (poor quality product administered), (product preparation error) (latency same day). Reportedly, reported called to ask if the ACTHIB dose needs to be repeated. They reported that one of their nurses reconstituted ACTHIB with sterile water and administered it to a patient. Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. More
2841971 4 F VA 05/21/2025 DTAP
DTAPIPV
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
JF7DM
4L454
Extra dose administered; Extra dose administered Extra dose administered; Extra dose administered
Patient received two doses of DTAP Patient received two doses of DTAP
2841972 72 M VA 05/21/2025 MMR
MERCK & CO. INC.
Y015995
Erythema, Peripheral swelling Erythema, Peripheral swelling
2 weeks after administration, patient woke with swelling and redness in hands, around all MCP's... 2 weeks after administration, patient woke with swelling and redness in hands, around all MCP's. This was temporary, and labs did not show any infection or significant underlying inflammatory condition. More
2841974 21 F 05/21/2025 COVID19
MODERNA

No adverse event, Underdose No adverse event, Underdose
MOD 6m-11yrs was accidentally administered to an adult. - No known adverse effects. MOD 6m-11yrs was accidentally administered to an adult. - No known adverse effects.
2841975 1.33 M IN 05/21/2025 DTAP
HEP
HEPA
HIBV
PNC20
VARCEL
SANOFI PASTEUR
MERCK & CO. INC.
MERCK & CO. INC.
MERCK & CO. INC.
PFIZER\WYETH
MERCK & CO. INC.
3CA25C1
Y002554
Y011731
X017447
HM0312
Y011017
Extra dose administered; Extra dose administered; Extra dose administered; Extra... Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered; Extra dose administered More
Patient was given a Hepatitis B fourth dose and no MMR first dose Patient was given a Hepatitis B fourth dose and no MMR first dose
2841976 19 F VA 05/21/2025 HEPA
MERCK & CO. INC.
X026485
Expired product administered Expired product administered
Expired vaccine was administered. Once documenting expiration date error was found. Doctor was infor... Expired vaccine was administered. Once documenting expiration date error was found. Doctor was informed and patient was notified. More
2841977 65 M FL 05/21/2025 COVID19
COVID19
PFIZER\BIONTECH
PFIZER\BIONTECH
PFR; EN6200
PFR; EN6200
Chest pain, Chills, Dizziness, Dyspnoea, Fatigue; Hyperhidrosis, Malaise, Palpit... Chest pain, Chills, Dizziness, Dyspnoea, Fatigue; Hyperhidrosis, Malaise, Palpitations, Scan myocardial perfusion More
2nd vaccination of COVID series given 3/12/21 (first given 2/19/21), and patient come to emergency d... 2nd vaccination of COVID series given 3/12/21 (first given 2/19/21), and patient come to emergency department on 5/24/21 with "two days of light headedness, chest pain, shortness of breath, and palpitations" however states that has had this previously. This has since resolved and underwent a cardiac work-up with preexisting cardiac stents, ruled out acute cardiac event though noted with new palpitations that was medically managed. More
โœ“
2841978 11 M NY 05/21/2025 HPV9
MNQ
MERCK & CO. INC.
SANOFI PASTEUR
7KD5B
U8369BA
Inappropriate schedule of product administration, No adverse event; Inappropriat... Inappropriate schedule of product administration, No adverse event; Inappropriate schedule of product administration, No adverse event More
Dose was administered inadvertently 18 days after the 1st dose of Menquadfi and 2nd dose of the HPV ... Dose was administered inadvertently 18 days after the 1st dose of Menquadfi and 2nd dose of the HPV was given. The pharmaceutical companies were contacted. There hasn't been any reported adverse events at the time this report is made More
2841979 32 F WI 05/21/2025 VARCEL
MERCK & CO. INC.
Y004555
Herpes zoster, Rash Herpes zoster, Rash
Shingles appearing rash to chest. Given valtrex and oral steroids Shingles appearing rash to chest. Given valtrex and oral steroids
2841980 12 F PA 05/21/2025 RAB
RAB
RAB
RAB
RAB
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
NOVARTIS VACCINES AND DIAGNOSTICS
FDP00595
FDP00595
FDP00595
FDP00595
FDP00595
Antinuclear antibody negative, Balance disorder, Blood creatine phosphokinase no... Antinuclear antibody negative, Balance disorder, Blood creatine phosphokinase normal, C-reactive protein normal, Decreased vibratory sense; Differential white blood cell count normal, Exercise tolerance decreased, Full blood count normal, Gait disturbance, Genetic testing; Glycosylated haemoglobin normal, Limb discomfort, Loss of personal independence in daily activities, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal; Metabolic function test normal, Muscular weakness, Pain in extremity, Red blood cell sedimentation rate normal, Reflex test normal; Thyroid function test normal, Urine analysis normal More
Patient was revaccinated on 3/20 with RIG due to not receiving RIG on 3/19 at R calf (site of scratc... Patient was revaccinated on 3/20 with RIG due to not receiving RIG on 3/19 at R calf (site of scratch from fox's tooth). Received 2nd dose of Rabies vaccine on 3/22, and 3rd rabies vaccine on 3/26/25. 4th shot on 4/2/25. On 3/31 started with bilateral leg weakness and reported inability to run. Legs felt achy and off blance. On 4/17 unable to participate in a fire drill due to leg pain and weakness. Due to ongoing symptoms was seen in the ED on 4/25 where she was noted to have more of an antalgic gait rather than weakness and intact/full strength bilaterally that became limited due to discomfort. Reflexes were intact and symmetric. Mild vibration sense deficiet distally noted in toe compared to ankle. MRI of entire spine and brain was unremarkable. Admitted to the hospital from 4/25-4/28 and during this time retained full strength. Genetic testing was obtained due to concerns for possible CMT. Abnormal gait not sugestive of weakness or cerebellar abnormalities but appeared to be more functional as she showed improvement on repetition. More
โœ“
2841981 52 F MA 05/21/2025 PNC20
VARZOS
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
LX4484
93N4J
Rash, Rash erythematous, Rash pruritic; Rash, Rash erythematous, Rash pruritic Rash, Rash erythematous, Rash pruritic; Rash, Rash erythematous, Rash pruritic
Patient seen 5/16 (4 days after vaccines administered) started noticing rash to her left upper arm ... Patient seen 5/16 (4 days after vaccines administered) started noticing rash to her left upper arm 5/13. Notes rash is progressively worsening. The affected area is on her left shoulder, characterized by redness, induration, and pain, described as itchy and similar to the sensation of being hit. This is the first time she has experienced such a reaction to a vaccine, although she had a mild reaction to the second COVID vaccine, which was not as severe. She has previously received the shingles vaccine without any issues. More
2841982 87 F MO 05/21/2025 PNC21
TDAP
MERCK & CO. INC.
GLAXOSMITHKLINE BIOLOGICALS
y019157
eb499
Injection site swelling; Injection site swelling Injection site swelling; Injection site swelling
Patient called the pharmacy the day after receiving the vaccines. Patient stated their right arm (w... Patient called the pharmacy the day after receiving the vaccines. Patient stated their right arm (where patient received Capvaxive vaccine) has a "swollen goose egg" where the vaccine was given. Patient states the swelling started a few hours after getting the vaccine. More
2841983 49 F OH 05/21/2025 TDAP
GLAXOSMITHKLINE BIOLOGICALS

Hypoaesthesia, Paraesthesia, Vaccination site mass Hypoaesthesia, Paraesthesia, Vaccination site mass
there is a lump at the vaccination site and my left hand pinky and ring fingers have been numb and t... there is a lump at the vaccination site and my left hand pinky and ring fingers have been numb and tingling since the vaccination. No treatment has been sought yet. More
2841984 60 F 05/21/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
332L4
Feeling cold, Pain Feeling cold, Pain
patient described full body hurting, especially her left shoulder and chilling beginning roughly 8 h... patient described full body hurting, especially her left shoulder and chilling beginning roughly 8 hours after injection. More
2841985 68 M NC 05/21/2025 RSV
RSV
PFIZER\WYETH
PFIZER\WYETH
LL8398
LL8398
Antinuclear antibody negative, Antinuclear antibody positive, Arthralgia, Immuno... Antinuclear antibody negative, Antinuclear antibody positive, Arthralgia, Immunoassay, Muscular weakness; Parvovirus B19 test negative, Spinal pain More
Within 2 hours of receiving RSV vaccine began having R shoulder and cervical spine sharp/arthritic p... Within 2 hours of receiving RSV vaccine began having R shoulder and cervical spine sharp/arthritic pain that worsened in severity over the day. Awoke next morning with R arm weakness, finally to the ER 5/9/25 where he was admitted for "possible vaccine related acute arthritis". Given IV steroids, transitioned to oral steroids prior to discharge when symptoms drastically improved, walking independently in hall. More
โœ“
2841986 0.17 M IN 05/21/2025 DTAPIPVHIB
SANOFI PASTEUR

Inappropriate schedule of product administration Inappropriate schedule of product administration
Patient received 2 month vaccine on 5-03-25 prior to being released from hospital and was given the ... Patient received 2 month vaccine on 5-03-25 prior to being released from hospital and was given the same vaccines in office again 5-16-25 More
2841987 22 M MN 05/21/2025 COVID19
FLU3
PFIZER\BIONTECH
SEQIRUS, INC.
LM2216
AW3227A
Dizziness, Loss of consciousness, Syncope; Dizziness, Loss of consciousness, Syn... Dizziness, Loss of consciousness, Syncope; Dizziness, Loss of consciousness, Syncope More
Prior to the vaccination, the patient stated that he sometimes gets lightheaded after vaccinations. ... Prior to the vaccination, the patient stated that he sometimes gets lightheaded after vaccinations. At approximately 2:45pm, the patient received both the covid and the flu vaccination. After the vaccination, the patient fainted while sitting in the chair and was assisted to the floor. He appeared to lose consciousness for around 30 seconds. At 2:50pm, he regained consciousness, with a BP of 120/68. At 3:00pm, his BP was 110/70. Nurse continued to monitor patient, as he drank some apple juice and water, and sat down for 15 additional minutes. After resting, patient stated he was "feeling fine". More
2841988 1.08 M WA 05/21/2025 HEPA
MMR
VARCEL
GLAXOSMITHKLINE BIOLOGICALS
MERCK & CO. INC.
MERCK & CO. INC.
A3X2K
Y004115
Y014181
Electroencephalogram, Febrile convulsion; Electroencephalogram, Febrile convulsi... Electroencephalogram, Febrile convulsion; Electroencephalogram, Febrile convulsion; Electroencephalogram, Febrile convulsion More
complex febrile seizure on 5/16/2025. seizure lasted 20 minutes complex febrile seizure on 5/16/2025. seizure lasted 20 minutes
2841989 66 M CA 05/21/2025 COVID19
PFIZER\BIONTECH
LP1776
Expired product administered, No adverse event Expired product administered, No adverse event
expired BioEntech vaccine 04/26/2025 given on 05/20/2025. Ni ill effects described at the time of ad... expired BioEntech vaccine 04/26/2025 given on 05/20/2025. Ni ill effects described at the time of administration More
2841990 62 M 05/21/2025 HEP
HEPA
DYNAVAX TECHNOLOGIES CORPORATION
GLAXOSMITHKLINE BIOLOGICALS


Arthralgia, Myalgia; Arthralgia, Myalgia Arthralgia, Myalgia; Arthralgia, Myalgia
Muscle and joint soreness in the arm/shoulder Muscle and joint soreness in the arm/shoulder
2841991 57 F CA 05/21/2025 COVID19
MODERNA
3044069
Chills, Headache Chills, Headache
Chills and Headache Chills and Headache
2841992 0.17 M PA 05/21/2025 DTAPHEPBIP
HIBV
PNC20
RV1
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS
PFIZER\WYETH
GLAXOSMITHKLINE BIOLOGICALS
9P329
2Z9F7
HN2630
32PF3
Sudden death; Sudden death; Sudden death; Sudden death Sudden death; Sudden death; Sudden death; Sudden death
sudden death within 24 hours sudden death within 24 hours
โœ“
2841993 43 F WA 05/21/2025 COVID19
COVID19
MODERNA
MODERNA
039021A
039021A
Antinuclear antibody, C-reactive protein, Differential white blood cell count, F... Antinuclear antibody, C-reactive protein, Differential white blood cell count, Fatigue, Full blood count; Pain, Paraesthesia, Rash, Red blood cell sedimentation rate, Urticaria More
With a few days I started having pins and needles in my thighs and round me hips. After about a wee... With a few days I started having pins and needles in my thighs and round me hips. After about a week of feeling it, I broke out in hives/rash, which was diagnosed by my primary doctor as shingles on 10/15/2025. Since there I have developed multiple health issues. Today I struggle with chronic fatigue, and constant body pains. Even laying down to sleep is painful More
2841994 72 F WI 05/21/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
PJ353
Abdominal pain upper, Chills, Nausea, Pyrexia Abdominal pain upper, Chills, Nausea, Pyrexia
NAUSEA, STOMACH PAIN, FEVER, CHILLS NAUSEA, STOMACH PAIN, FEVER, CHILLS
2841995 78 F MA 05/21/2025 PNC21
MERCK & CO. INC.
Y019157
Pruritus, Skin warm Pruritus, Skin warm
ITCHY AND WARM TO THE TOUCH. ITCHY AND WARM TO THE TOUCH.
2841997 34 F WA 05/21/2025 HEPA
HEPA
GLAXOSMITHKLINE BIOLOGICALS
GLAXOSMITHKLINE BIOLOGICALS


Chills, Constipation, Diarrhoea, Headache, Pyrexia; Vomiting Chills, Constipation, Diarrhoea, Headache, Pyrexia; Vomiting
SEVERE vomiting, fever, chills, constipation with diarrhea, pounding headache SEVERE vomiting, fever, chills, constipation with diarrhea, pounding headache
2841998 58 F 05/21/2025 PNC21
TDAP
VARZOS
MERCK & CO. INC.
SANOFI PASTEUR
GLAXOSMITHKLINE BIOLOGICALS
Y019158
U8232AA
F95YS
Paraesthesia; Paraesthesia; Paraesthesia Paraesthesia; Paraesthesia; Paraesthesia
Patient received Adacel, Capvaxive, and 1st dose of Shingrix. Within about 2 minutes of completing v... Patient received Adacel, Capvaxive, and 1st dose of Shingrix. Within about 2 minutes of completing vaccine administration, patient complained of severe sharp pain in her back. She sat on the bench for a few minutes outside of the pharmacy. We took her blood pressure and pulse and those numbers appeared normal. Patient complained of no swelling or trouble breathing. She said her lips and cheeks were a little "tingly". Patient remained seated on the bench by the pharmacy for about 30 minutes. Her back pain significantly improved. She did say her lips still felt "tingly". Recommended patient to get otc benadryl to help with possible allergic reaction. Gave the patient 2 tablets of ibuprofen from my personal bottle. Patient left with her husband. Told them to go to ER if patient has trouble breathing. More
2841999 51 F MD 05/21/2025 UNK
UNKNOWN MANUFACTURER
Y019158
Fatigue, Headache, Injection site irritation, Pain, Pyrexia Fatigue, Headache, Injection site irritation, Pain, Pyrexia
received Capvaxive vaccine and developed fever, body aches, irritation at injection, physical exhaus... received Capvaxive vaccine and developed fever, body aches, irritation at injection, physical exhaustion, headache the evening after she got the vaccine. More
2842000 46 F WA 05/21/2025 COVID19
PFIZER\BIONTECH
MD3414
Chest pain, Oedema peripheral, Pain Chest pain, Oedema peripheral, Pain
Starting 5/20/25 evening: - Intermittent chest pain Shooting Pain - Radiates from her right side to ... Starting 5/20/25 evening: - Intermittent chest pain Shooting Pain - Radiates from her right side to her left side Swelling - Significant swelling in her armpits treating with: tylenol and ibuprofen - minimal relief More
2842001 4 F OK 05/21/2025 DTAPIPV
GLAXOSMITHKLINE BIOLOGICALS
Y49BZ
Peripheral swelling Peripheral swelling
Localized swelling with induration approximately 15cm x 14cm right thigh started 24hrs after vaccina... Localized swelling with induration approximately 15cm x 14cm right thigh started 24hrs after vaccination. Started as quarter sized & enlarged to triple size over night. More
2842002 68 F CA 05/21/2025 PNC20
RSV
PFIZER\WYETH
PFIZER\WYETH
LC1279
LN5487
Intraocular pressure increased; Intraocular pressure increased Intraocular pressure increased; Intraocular pressure increased
A patient reported experiencing an increase in eye pressure, describing the sensation as if her eyes... A patient reported experiencing an increase in eye pressure, describing the sensation as if her eyes were "popping out." She sought medical attention and was prescribed multipe eye drops to alleviate the pressure. While the exact timeline was unclear, the patient began her eye drop prescription approximately two months after receiving her vaccination. The patient beliees her eye issues are linked to receiving two vaccines simultaneously, caliming that pharmacist "forced" or "promoted" her to get both at the same time. 12/30/2024 simbrinza 02/18/2025 latanoprost, dorzolamide 04/15/2025 loteprednol 05/02/2025 brimonidine More
2842003 75 F DC 05/21/2025 VARZOS
GLAXOSMITHKLINE BIOLOGICALS
MG5S9
Extra dose administered, No adverse event Extra dose administered, No adverse event
Patient is not experiencing any adverse effects Patient is not experiencing any adverse effects
2842004 0.58 M MD 05/21/2025 DTPPVHBHPB
PNC20
RV5
MSP VACCINE COMPANY
PFIZER\WYETH
MERCK & CO. INC.
UU7788AA
LN4929
Y014320
Eye movement disorder, Hyporesponsive to stimuli, Immediate post-injection react... Eye movement disorder, Hyporesponsive to stimuli, Immediate post-injection reaction, Pallor, Respiratory arrest; Eye movement disorder, Hyporesponsive to stimuli, Immediate post-injection reaction, Pallor, Respiratory arrest; Eye movement disorder, Hyporesponsive to stimuli, Immediate post-injection reaction, Pallor, Respiratory arrest More
Child had an episode immediately following vaccinations consisting of decreased responsiveness, pall... Child had an episode immediately following vaccinations consisting of decreased responsiveness, pallor, "eyes rolled back". Mom reported "not breathing". Mom reported episode lasted 10 seconds, MA reported a few seconds. More